Xenna is developing NADPH inhibiting antimetabolite and anti-androgen therapeutics with anticancer potential, but is initially offering a line of consumer products consisting of denaturing dermatologicals for hyperkeratotic nail, skin, and hair conditions.
You may also be interested in...
If President Donald Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsburg, Affordable Care Act coverage could disappear. Two legal experts weigh in on this and other legal issues that could touch the medical device industry.
The Dutch start-up will use the funds to finalize product design for a neurostimulation platform targeting chronic migraines.
Signifier Medical Technologies is ramping up commercialization of its technology solutions for patients with snoring and sleep disordered breathing conditions.